Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in fistulizing Crohn's disease
2005-005363-28Phase 3Completed
- Sponsor
- Ocera Therapeutics
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing AST-120 with Placebo (2 arms). Started Jan 2006; status: completed.
02
Drugs
activated charcoal
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-005363-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005363-28.